Fulgent Genetics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	721	565	857	900	3,001	1,265
Market Cap Growth	41.75%	-34.06%	-4.82%	-70.00%	137.28%	366.87%
Enterprise Value	-59	-244	28	26	2,160	1,163
Last Close Price	23.60	18.47	28.91	29.78	100.59	52.10
PE Ratio	-	-	-	6.28	5.91	5.90
Forward PE	-	-	-	-	13.80	7.11
PS Ratio	2.28	1.99	2.96	1.45	3.02	3.00
PB Ratio	0.65	0.50	0.76	0.71	2.57	2.22
P/TBV Ratio	0.75	0.58	0.88	0.93	2.80	2.22
P/FCF Ratio	-	-	178.63	3.83	5.83	11.99
P/OCF Ratio	473.12	26.83	31.73	3.55	5.57	8.99
PEG Ratio	-	0.20	0.20	0.20	0.20	0.20
EV/Sales Ratio	-	-	0.10	0.04	2.18	2.76
EV/EBITDA Ratio	-	-	-	0.12	3.14	3.97
EV/EBIT Ratio	-	-	-	0.14	3.20	4.01
EV/FCF Ratio	-	-	5.91	0.11	4.20	11.03
Debt / Equity Ratio	0.01	0.01	0.02	0.03	0.03	0.03
Debt / EBITDA Ratio	-	-	-	0.17	0.04	0.05
Debt / FCF Ratio	-	-	3.45	0.16	0.06	0.15
Net Debt / Equity Ratio	-0.70	-0.73	-0.73	-0.64	-0.78	-0.73
Net Debt / EBITDA Ratio	16.66	16.72	16.91	-3.80	-1.32	-1.42
Net Debt / FCF Ratio	39.28	42.55	-173.30	-3.47	-1.76	-3.95
Asset Turnover	0.26	0.23	0.22	0.47	1.00	1.07
Quick Ratio	6.28	4.60	6.60	6.83	5.64	3.87
Current Ratio	7.01	4.85	6.96	7.13	5.81	4.02
Return on Equity (ROE)	-3.92%	-3.87%	-14.58%	11.65%	58.35%	65.72%
Return on Assets (ROA)	-3.62%	-3.76%	-3.59%	8.51%	42.69%	45.96%
Return on Invested Capital (ROIC)	-8.99%	-9.21%	-9.99%	18.33%	97.45%	126.48%
Return on Capital Employed (ROCE)	-6.20%	-6.40%	-6.50%	14.00%	57.60%	50.90%
Earnings Yield	-5.97%	-7.56%	-19.59%	15.93%	16.91%	16.95%
FCF Yield	-2.75%	-3.41%	0.56%	26.08%	17.16%	8.34%
Buyback Yield / Dilution	-2.27%	-1.51%	3.81%	0.04%	-28.77%	-28.58%

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q